20550 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters; Glycosaminoglycans, i.e. mucopolysaccharides Heparin; Heparan
Heparin-based compositions and methods for the inhibition of metastasis
#602Multi-arm polyethylene glycol derivatives, conjugates and gels of pharmaceuticals and the same
#603Wound treatments with crosslinked protein amorphous biomaterials
#604Hybrid stent and method of making
#605POLYMERIC MATERIALS INCLUDING A GLYCOSAMINOGLYCAN NETWORKED WITH A POLYOLEFIN-CONTAINING POLYMER
#606GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS, METHODS OF DETECTION AND USES THEREOF
#607PROCESS FOR THE PREPARATION OF HIGHLY O-SULFATED EPIMERIZED DERIVATIVES OF K5 POLYSACCHARIDE AND INTERMEDIATES THEREIN
#608Infarction treatment compositions and methods
#609INJECTABLE COMPOSITIONS FOR INTRA-ARTICULAR USE COMBINING A VISCOSUPPLEMENTATION AGENT AND A FIBROBLAST GROWTH MEDIUM
#610Isolation and characterisation of heparan sulphates and their use in pharmaceutical compositions, methods of treatment and stem cell culture media suitable for conditions associated with bone repair
#611Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
#612Use of sulfated glycosaminoglycans for establishing effective labor in women
#613Freeze-dried fibrin matrices and methods for preparation thereof
#614Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
#615Immobilized biologically active entities having a high degree of biological activity
#616KITS AND IMPROVED COMPOSITIONS FOR TREATING LOWER URINARY TRACT DISORDERS
#617SENSITIZATION OF CANCER CELLS TO TREATMENT
#618Modulation of synaptic maintenance
#619Granulysin in immunotherapy
#620Polysaccharide gel formulation having multi-stage bioactive agent delivery
#621Methods for hematopoietic precursor mobilization
#622Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders
#623DIAGNOSTIC AND PROGNOSTIC ASSAY
#624DRY POWDER COMPOSITION COMPRISING CO-JET MILLED PARTICLES FOR PULMONARY INHALATION
#625LOCAL VASCULAR DELIVERY OF ADENOSINE A2A RECEPTOR AGONISTS TO REDUCE MYOCARDIAL INJURY
#626Methods for treating bleeding disorders using sulfated polysaccharides
#627Vasoprotective and cardioprotective antidiabetic therapy
#628USE OF AN ACYLATED OCTASACCHARIDE AS AN ANTITHROMBOTIC AGENT
#629BIOACTIVE COMPOSITION INCLUDING STABILIZED PROTEIN AND PROCESS FOR PRODUCING THE SAME
#630Modified amino acid for the inhibition of platelet aggregation
#631Heparan sulphate
#632Lipid conjugates in the treatment of allergic rhinitis
#633METHOD FOR BLOCKING LIGATION OF THE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS (RAGE)
#634Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate
#635Lipid conjugates in the treatment of chronic rhinosinusitis
#636Multi-Functional Biocompatible Coatings for Intravascular Devices
#637ADMINISTRATION OF ENOXOPARIN SODIUM TO PATIENTS 75 YEARS AND OLDER WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
#638Bioactive hydrogel
#639Method of treating thrombocytopenia
#640DOSE OF AVE5026 FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL IMPAIRMENT
#641Compositions for achieving a therapeutic effect in an anatomical structure
#642Antimicrobial hydrochloric acid catheter lock solution and method of use
#643Drug Combinations Useful for Prevention of Restenosis
#644BIOMARKERS FOR DIAGNOSIS OF TRANSIENT ISCHEMIC ATTACKS
#645Perlecan domain V protects, repairs and restores ischemic brain stroke injury and motor function
#646Intravascular indwelling catheter lock solution containing weak acid and container containing the same
#647Transdermal venous access locking solutions
#648USE OF A CHITOSAN POLYMER FOR HEPARIN NEUTRALIZATION
#649Immobilized biologically active entities having a high degree of biological activity
#650Promoter for hard tissue formation
#651Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations
#652SYNTHETIC GLYCOLIPID-CONTAINING LIPOSOME
#653Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
#654PHARMACEUTICAL COMPOSITION OF COMPLEX CARBOHYDRATES AND ESSENTIAL OILS AND METHODS OF USING THE SAME
#655Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
#656Method for manufacturing a porous ceramic scaffold having an organic/inorganic hybrid coating layer containing a bioactive factor
#657Tissue matrix system
#658Methods for treating bleeding disorders using sulfated polysaccharides
#659Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
#660COAGULATION FACTOR MODULATION FOR CONTROLLING TRANSPLANT ORGAN SIZE
#661INHIBITION OF INTER-ALPHA TRYPSIN INHIBITOR FOR THE TREATMENT OF AIRWAY DISEASE
#662PHYSICALLY STABILIZED BIODEGRADABLE OSTEOCHONDRAL IMPLANT AND METHODS FOR ITS MANUFACTURE AND IMPLANTATION
#663MUCOACTIVE AGENTS FOR TREATING A PULMONARY DISEASE
#664Keratin biomaterials for treatment of ischemia
#665COMPOSITIONS AND METHODS FOR TREATING CHRONIC RESPIRATORY INFLAMMATION
#666METHODS FOR PREVENTING AGGREGATION OF ADIPOSE STROMAL CELLS
#667Evaluating heparin preparations
#668PHARMACEUTICAL COMPOSITION WITH GLYCOSAMINOGLYCANS AND USE THEREOF IN THE TREATMENT OF CHRONIC ULCERS
#669Oxidized heparin fractions and their use in inhibiting angiogenesis
#670Method of making a hybrid stent
#671METHODS OF TREATING THROMBOEMBOLIC DISORDERS
#672Repair and/or reconstitution of invertebral discs
#673Method for removing cytokines from blood with surface immobilized polysaccharides
#674Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
#675Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
#676Composition of dialysis liquid comprising crystallisation inhibitor substances
#677Heparan sulphate which binds BMP2
#678Isolation and Identification of Glycosaminoglycans
#679Medical implants and methods of making medical implants
#680VON WILLEBRAND FACTOR SPECIFIC BINDERS AND METHODS OF USE THEREFOR
#681COMPOSITIONS OF POLYSACCHARIDES DERIVED FROM HEPARIN, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#682USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS
#683LIPID-POLYMER CONJUGATES, THEIR PREPARATION AND USES THEREOF
#684SEPARATION OF POLYSACCHARIDES BY CHARGE DENSITY GRADIENT
#685Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXI
#686Oral formulations of cladribine
#687Coating system and method for drug elution management
#688COMBINATION ANTIHISTAMINE MEDICATION
#689Composition and method for the repair and regeneration of cartilage and other tissues
#690METHODS OF MAKING LOW MOLECULAR WEIGHT HEPARIN COMPOSITIONS
#691METHOD OF PREVENTING FIBRIN CLOTS IN PULMONARY TISSUE THROUGH THE USE OF AEROSOLIZED ANTICOAGULANTS
#692Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment
#693Preparation for body surface application and preparation for body surface application-holding sheet
#694Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
#695Compounds and method for coating surfaces in a hemocompatible manner
#696DESIGN AND SELECTION OF MEDICAMENTS THAT MODULATE THE FUNCTION AND ACTIVITY OF INTERLEUKIN 13
#697Sodium thiosulfate-containing pharmaceutical compositions
#698METHOD OF USING ENOXAPARIN FOR REDUCING THE RISK OF DEATH IN ACUTELY ILL MEDICAL PATIENTS
#699Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
#700AMINOSUGAR, GLYCOSAMINOGLYCAN, AND S-ADENOSYLMETHIONINE COMPOSITION FOR THE TREATMENT AND REPAIR OF CONNECTIVE TISSUE
#701Nanoparticles for protein drug delivery
#702Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
#703Silver nanoparticles as anti-microbial
#704Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
#705Controlled Iodine Release Particle Micro-Biocide
#706ANTIOXIDANT AND PARAMAGNETIC HEPARIN-NITROXIDE DERIVATIVES
#707Non-anticoagulant polysaccharide compositions
#708Multifunctional and biologically active matrices from multicomponent polymeric solutions
#709Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#710TETRACYCLINE AND USES THEREOF
#711Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon
#712IMMOBILIZED BIOLOGICALLY ACTIVE ENTITIES HAVING A HIGH DEGREE OF BIOLOGICAL ACTIVITY FOLLOWING STERILIZATION
#713Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
#714Self-repairing cyclic oxide-substituted chitosan polyurethane networks
#715Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III
#716Transdermal venous access locking solution
#717Method and system for producing a substance or a signal with a coagulating or anticoagulant effect
#718Non-nucleotide composition for inhibiting platelet aggregation
#719USE OF SUBSTRATES AS PHARMACOLOGICAL CHAPERONES
#720METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#721Compositions and methods of treating viral infections
#722Method for screening a test substance for activating a receptor associated with FGF 21 activity
#723Freeze-dried fibrin matrices and methods for preparation thereof
#724Means and methods for the recruitment and identification of stem cells
#725USE OF COAGULATION PROTEINS TO LYSE CLOTS
#726Administration of Enoxoparin Sodium to Patients 75 Years and Older With ST-Segment Elevation Myocardian Infarction
#727Complement inhibition for improved nerve regeneration
#728Modulation of factor 11 expression
#729METHODS AND COMPOSITIONS RELATED TO MODULATING THE EXTRACELLULAR STEM CELL ENVIRONMENT
#730Nanospheres encapsulating bioactive material and method for formulation of nanospheres
#731Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders
#732Polysaccharide gel formulation having multi-stage bioactive agent delivery
#733Use of lipid conjugates in the treatment of conjunctivitis
#734Heparin Compositions and Selectin Inhibition
#735HEPARINS INCLUDING AT LEAST ONE COVALENT BOND WITH BIOTIN OR A BIOTIN DERIVATIVE, METHOD FOR PREPARING SAME AND USE THEREOF
#736Prevention and/or treatment of neurodegenerative disorders
#737Methods for analyzing or processing a heparin sample
#738Evaluating heparin preparations for pharmaceutical use
#739COMBINATION THERAPY FOR INHIBITION OF PLATELET AGGREGATION
#740PHARMACEUTICAL COMPOSITIONS CONTAINING HEPARIN DERIVATIVES
#741Polysaccharide gel formulation having increased longevity
#742Compounds and compositions for delivering active agents
#743AMINOSUGAR, GLYCOSAMINOGLYCAN, AND S-ADENOSYLMETHIONINE COMPOSITION FOR THE TREATMENT AND REPAIR OF CONNECTIVE TISSUE
#744SELECTED BETAINES AND THEIR USES
#745Modified Glycosaminoglycans, Pharmaceutical Compositions and Methods for Oral Delivery Thereof
#746Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
#747Methods for treating bleeding disorders using sulfated polysaccharides
#748NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN
#749Heparin Prodrugs and Drug Delivery Stents Formed Therefrom
#750Heparin prodrugs and drug delivery stents formed therefrom
#751Heparin Prodrugs and Drug Delivery Stents Formed Therefrom
#752Heparin prodrugs and drug delivery stents formed therefrom
#753Novel Use of Bivalirudin in the Treatment of Acute Coronary Syndrome
#754METHODS FOR CONTROLLING INTRACELLULAR CALCIUM LEVELS ASSOCIATED WITH AN ISCHEMIC EVENT
#755Methods and compositions for increasing RNA interference
#756TREATMENT AND PREVENTION OF ABNORMAL CELLULAR PROLIFERATION
#757Drug/Drug Deliver Systems For The Prevention And Treatment Of Vascular Disease
#758Nogo-Receptors and Methods of Use
#759Biocompatible hydrogel compositions
#760Heparin conjugates and methods
#761USE FOR A VERY LOW MOLECULAR WEIGHT HEPARINS
#762Methods of culturing mesenchymal stem cells
#763Polysaccharide gel formulation having increased longevity
#764Targeted short-lived drug delivery
#765Targeted short-lived drug delivery
#766Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#767GLYCOSAMINOGLYCANS DERIVED FROM K5 POLYSACCHARIDE HAVING HIGH ANTICOAGULANT AND ANTITHROMBOTIC ACTIVITIES AND PROCESS FOR THEIR PREPARATION
#768Heparin coating of biological tissue
#769METHODS OF TREATING ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#770Drug eluting coatings for medical implants
#771METHOD FOR BLOCKING LIGATION OF THE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS (RAGE)
#772Promoter For Hard Tissue Formation
#773Process for the preparation of N-acyl-(epi)K5-amine-O-sulfate-derivatives and products thus obtained
#774Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same
#775Chitosan and Heparin Nanoparticles
#776Self Assembled Films for Protein and Drug Delivery Applications
#777Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
#778MODIFIED AMINO ACID FOR THE INHIBITION OF PLATELET AGGREGATION
#779Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization
#780Composition forstimulating bone growth and differentiation and method for isolating same
#781Use of sulfated glycosaminoglycans for establishing effective labor in women
#782Preparation and application of heparin silver
#783Percutaneously Absorbable Preparation, Percutaneously Absorbable Preparation Holding Sheet, and Percutaneously Absorbable Preparation Holding Equipment
#784Compositions Comprising Glycosaminoglycan and Nonsteroidal Anti-Inflammatory Drug
#785Chitosan-Based Particles
#786Nanoparticles for protein drug delivery
#787Methods to Inhibit Histone Acetyltransferase Using Glycosaminoglycans
#788Nanoparticles for protein drug delivery
#789Hybrid stent and method of making
#790NEUROPROTECTION BY BLOOD FLOW STABILIZATION
#791Orthogonally protected disaccharide building blocks for synthesis of heparin
#792Aryl ketone compounds and compositions for delivering active agents
#793Positive Modulator of Bone Morphogenic Protein-2
#794Nanoparticles for drug delivery
#795Diagnosis and treatment of cancer related to human dormancy
#796Compositions capable of facilitating penetration across a biological barrier
#797Combination of Inorganic Hemostatic Agents with Other Hemostatic Agents
#798Thyroid hormone analogs and methods of use
#799Heparin compositions that inhibit clot associated coagulation factors
#800Growth Factor Composition
#801Use of lipid conjugates in the treatment of diseases or disorders of the eye
#802USE OF DIPYRIDAMOLE OR MOPIDAMOL FOR TREATMENT AND PREVENTION OF FIBRIN-DEPENDENT MICROCIRCULATION DISORDERS
#803Contact lens compositions
#804METHOD AND COMPOSITION FOR PREVENTING PAIN IN SICKLE CELL PATIENTS
#805Non-nucleotide composition and method for inhibiting platelet aggregation
#806Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
#807Immobilized biologically active entities having a high degree of biological activity
#808Methods of drug delivery using sulphated chitinous polymers
#809Methods using glycosaminoglycans for the treatment of nephropathy
#810Biocompatible stent
#811Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
#812Aminosugar, glycosaminoglycan, and s-adenoslymethionine composition for the treatment and repair of connective tissue
#813Methods and compositions using sulodexide for the treatment of diabetic nephropathy
#814Protection From And Treatment Of Prion Protein Infection
#815Hydrophobic biomolecular structure
#816Compositions capable of facilitating penetration across a biological barrier
#817System and method for promoting coronary angiogenesis
#818Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage
#819Nanoparticles for protein/peptide delivery and delivery means
#820Polyesteramide platform for site specific drug delivery
#821Nanoparticles for drug delivery
#822Method for Treating or Inhibiting the Effects of Injuries or Diseases that Result in Neuronal Degeneration
#823Methods and compositions comprising at least one alpha3 beta4 nAChR antagonist or pharmaceutically acceptable salt thereof
#824Solid dosage form of wetted heparin
#825Nonexpansion Protocol for Autologous Cell-Based Therapies
#826COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER
#827COMPOSITIONS AND COATINGS FOR IMPLANTABLE MEDICAL DEVICES
#828COMPOSITIONS COMPRISING POROUS ARTICLES AND USES IN IMPLANTABLE MEDICAL DEVICES
#829COATINGS FOR IMPLANTABLE MEDICAL DEVICES
#830COATINGS FOR IMPLANTABLE MEDICAL DEVICES
#831Implantable device prepared from solution processing
#832Oral formulations of cladribine
#833Methods of determining activity of ryanodine receptor modulators
#834Drug delivery methods and devices
#835Methods for performing percutaneous coronary intervention
#836Active hedgehog protein conjugate
#837SINGLE-DOSE NEEDLE-FREE ADMINISTRATION OF ANTITHROMBOTIC MEDICATIONS
#838Use of lipid conjugates in cystic fibrosis and applications thereof
#839FIBRONECTIN-MODIFIED ECM TISSUE GRAFT CONSTRUCTS AND METHODS FOR PREPARATION AND USE THEREOF
#840Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon
#841Medical Devices, Drug Coatings And Methods for Maintaining the Drug Coatings Thereon
#842Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon
#843Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon
#844Method and means for treating solid tumors
#845Method and means for treating solid tumors
#846Methods and means for treating solid tumors
#847Methods Using Sulodexide for the Treatment of Bladder Disease
#848Drug Delivery System for Retarding Release of Water Soluble Drugs
#849Transluminal drug delivery methods and devices
#850Transluminal drug delivery methods and devices
#851Methods for evaluating the quality of a heparin sample
#852Use of lipid conjugates in the treatment of conjunctivitis
#853Sterilized peritoneal dialysis solutions containing heparin
#854Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof
#855Sustained release pharmaceutical compositions
#856Internal medical devices containing peroxide-converting catalysts
#857Angiogenically effective unit dose of FGF-2 and method of use
#858Use of cathepsin s inhibitors for treating an immune response caused by administration of a small molecule therapeutic or biologic
#859Modulation of synaptic maintenance
#860Use of clusterin for the treatment and/or prevention of peripheral neurological diseases
#861Secreted neural apoptosis inhibiting proteins
#862Methods of Preventing Morbidity and Mortality by Perioperative Administration of a Blood Clotting Inhibitor
#863Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome
#864COMPOSITIONS AND METHODS FOR THE PULMONARY DELIVERY OF AEROSOLIZED MEDICAMENTS
#865Tissue preservation with a salt solution isotonic with interstitial fluids
#866Methods of treatment using vascular occlusion in combination therapies
#867Orally bioavailable compounds and methods for inhibiting platelet aggregation
#868Compounds and compositions for delivering active agents
#869INTRALUMINAL DEVICES FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASE
#870Reiteratively layered medical devices and method of preparing same
#871Seaweed extract composition for treatment of diabetes and diabetic complications
#872Combination therapy for inhibition of platelet aggregation
#873Dry powder composition comprising a benzodiazepine for pulmonary inhalation
#874Use of lipid conjugates in the treatment of disease
#875Maternal chelation for embryo, fetal, and infant benefit
#876Methods and producing low molecular weight heparin
#877Mucoactive agents for treating a pulmonary disease
#878Polysaccharide-functionalized nanoparticle, drug delivery system for controlled release comprising the same and preparation method thereof
#879Drugs coated on a device to treat vulnerable plaque
#880Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments
#881Coating composition for polymeric surfaces comprising serpin or serpin derivatives
#882Composition and method for the repair and regeneration of cartilage and other tissues
#883Nogo-receptors and methods of use
#884Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
#885Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease
#886Coagulation proteins, coagulation-anticoagulation protein complexes, derivatives thereof and their uses
#887Heparin compositions and selectin inhibition
#888Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability
#889Methods and compositions related to modulating the extracellular stem cell environment
#890Methods for selectively treating COX-2 mediated disorders by administering gamma-tocopherol
#891Method for treating or inhibiting the effects of injuries or diseases that result in neuronal degeneration and method for promoting neurogenesis
#892Administration of enoxaparin sodium to patients with severe renal impairment
#893Administration of enoxaparin sodium to patients with severe renal impairment
#894Use of lipid conjugates in the treatment of disease
#895Methods for preparing pharmaceutical compositions
#896Administration of enoxaparin sodium to patients 75 years and older with ST-segment elevation myocardial infarction
#897Glycosaminoglycans derived from the K5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
#898Anti-infective iodine based compositions for otic and nasal use
#899Use of coagulation proteins to lyse clots
#900Combination antihistamine medication